Innovation and Research Fund

The Urology Foundation (TUF) will fund projects up to a value of £60,000 that seek to use new, exciting, innovative approaches to address urological diseases and disorders.

Click here to read more about the TUF Innovation and Research Fund


 We are an NIHR Partner. Find out how that can help you fund your research.


Innovation and Research Fund 2024

Applications are now open. Deadline for entries is 31 January 2024.

How to apply 

1.  Downland and complete the APPLICATION FORM and guidance document CLICK HERE   NB: Note new Section 8.9 on use of Generative AI Tools.

    For more information about the award, read the TUF Innovation and Research Fund Call document here.

2. Send your application to us by 23:59 on 31 January 2024

3. If you have received a TUF grant before, please click here to make sure you are eligible to apply again. 

If you have any queries about the application process, please email the office at This email address is being protected from spambots. You need JavaScript enabled to view it.

The deadline for 2024 applications is 31 January 2024

N.B. Applications are accepted up to midnight on the deadline.

Our funding comes with the following provisions: 

  • Research must be carried out in the UK or Ireland.
  • Applications are subject to rigorous review by our Review Panel and our Scientific and Education Committee.
  • Successful applicants must provide a satisfactory progress report to secure the final grant instalment. You're also encouraged to submit abstracts to the British Association of Urological Surgeon’s (BAUS) Annual Meeting.

Please note that TUF Innovation and Research Fund is an individual award: The named applicant must be the person carrying out the research.


We are pleased to have funded the following projects in 2023:  

Alasdair Hubbard Nottingham Trent University Clinically relevant study of antimicrobial resistance evolution in uropathogenic Escherichia coli using a model of the human bladder
Alan McWilliam Uni of Manchester / Christie Impact of body composition on patient outcomes in the STAMPEDE trial
Joseph Santiapillai UCL / Royal Free Hospital INVestigation Of Immune Priming Interventions in Kidney CancEr (INVOKE)
Kate Manley NNUH / UEA DESNT biomarker for the prediction of prostate cancer outcomes
Nikhil Mayor Imperial College London Ex vivo real-time analysis of radical prostatectomy margins using fluorescence confocal microscopy (FCM): are “digital frozen sections” the future?
Nikolitsa Nomikou University College London Augmenting the efficacy of sonodynamic therapy against metastatic castration-resistant prostate cancer
Priyanka Krishnaswamy Uni of Newcastle Oestrogen, DNA methylation and the susceptibility of post-menopausal women to recurrent urinary tract infections
Rebecca Hall Uni of Newcastle A Postal Pilot Study for a National Lynch Syndrome Urothelial Cancer Screening Programme based on Urine Analysis using the Newcastle MSI-Plus Assay

Events for professionals